Branko Cuglievan

9PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRegenerative medicine (incl. stem cells)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 27, 2026
Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.

|Jun 11, 2026
All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE).

|Mar 12, 2026
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.

Sanam Loghavi, Aziz Farhat, Trevor J Jamison

|Jun 09, 2025
Trends in Radiation Use from 2004 to 2020 among Adolescents and Young Adults with Hodgkin Lymphoma.

Kelsey L Corrigan, Amy M Berkman, Jillian Gunther

|Apr 14, 2025
Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras.

Vivek Subbiah, Megan Othus, Jim Palma

|Aug 23, 2024
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community.

Branko Cuglievan, Hagop Kantarjian, Jeffrey E Rubnitz

Pageof 2

Frequent Collaborators

4 joint publications

David McCall

4 joint publications

Miriam Garcia

3 joint publications

Hagop M Kantarjian

3 joint publications

Courtney D DiNardo